KOL kliniske forsøg i Wisconsin
8 studier for KOL søger deltagere på steder i Wisconsin.
Byer i Wisconsin
Officiel studietekst (engelsk)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Cudahy
- Research Site, Milwaukee
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 2. okt. 2026 · NCT06283966An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Medical College of Wisconsin (MCW), Milwaukee
Rekrutterer
Alder 40 til 80 · Alle køn · Opdateret 17. sep. 2026 · NCT06035120A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Madison
RekruttererFase 2
Alder 40 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Cudahy
- Research Site, Milwaukee
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06883305COPD Exacerbation Follow Up
- Aurora St. Luke's Medical Center, Milwaukee
RekruttererObservationsstudie
Alder 40 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT07118306Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Medical College of Wisconsin, Milwaukee
Rekrutterer
Alder 40 til 80 · Alle køn · Opdateret 28. apr. 2026 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Medical College of Wisconsin, Milwaukee
Rekrutterer
Alder 40 til 84 · Alle køn · Opdateret 24. apr. 2026 · NCT06891755Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Ascension Columbia St. Mary's Wisconsin, Milwaukee
RekruttererObservationsstudie
Alder 50 og opefter · Alle køn · Opdateret 5. aug. 2025 · NCT06122077Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.